share_log

RBC Capital Maintains Sector Perform on Gilead Sciences, Lowers Price Target to $74

Benzinga ·  Apr 26 11:46

RBC Capital analyst Brian Abrahams maintains Gilead Sciences (NASDAQ:GILD) with a Sector Perform and lowers the price target from $76 to $74.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment